These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 3708889

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Annular subacute cutaneous lupus erythematosus responsive to dapsone.
    McCormack LS, Elgart ML, Turner ML.
    J Am Acad Dermatol; 1984 Sep; 11(3):397-401. PubMed ID: 6480948
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Urticaria-like lesions associated with systemic lupus erythematosus: response to dapsone.
    Matthews CN, Saihan EM, Warin RP.
    Br J Dermatol; 1978 Oct; 99(4):455-7. PubMed ID: 708619
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dapsone-induced aplastic anemia in a woman with bullous systemic lupus erythematosus.
    Meyerson MA, Cohen PR.
    Mayo Clin Proc; 1994 Dec; 69(12):1159-62. PubMed ID: 7967777
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of chronic lupus erythematosus with dapsone].
    Nguyen-Van-Ut.
    Ann Dermatol Venereol; 1984 Dec; 111(12):1125. PubMed ID: 6529082
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency.
    Holtman JH, Neustadt DH, Klein J, Callen JP.
    J Rheumatol; 1990 Sep; 17(9):1222-5. PubMed ID: 2290166
    [Abstract] [Full Text] [Related]

  • 12. Vesico-bullous subacute cutaneous lupus erythematosus--an uncommon entity successfully treated with dapsone and hydroxychloroquine.
    Pinto-Almeida T, Sanches M, Alves R, Selores M.
    Dermatol Online J; 2012 Aug 15; 18(8):13. PubMed ID: 22948063
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dapsone induced sulfone syndrome and systemic lupus exacerbation.
    Kraus A, Jakez J, Palacios A.
    J Rheumatol; 1992 Jan 15; 19(1):178-80. PubMed ID: 1556687
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Systemic Lupus Erythematosus and Bullous Pemphigoid with Dramatic Response to Dapsone.
    Maggio MC, Corsello G, Prinzi E, Cimaz R.
    Am J Case Rep; 2017 Mar 29; 18():317-319. PubMed ID: 28352068
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dapsone in cutaneous lesions of SLE: an open study.
    Singh YN, Adya CM, Verma KK, Kumar A, Malaviya AN.
    J Assoc Physicians India; 1992 Nov 29; 40(11):735-6. PubMed ID: 1307535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.